Prophylactic perioperative β-blockade reduces cardiac morbidity and mortality following non-cardiac surgery in patients at risk;Profylactische perioperatieve β-blokkade ter vermindering van cardiale morbiditeit en sterfte bij risicopatiënten die een niet-cardiale operatie ondergaan

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 6, 2004, Pages 268-275

  Damen, J ^a   Bax, J J ^b   Kolkman, E ^c   Poldermans, D ^d  

^a ISALA HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Diagram   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CIMETIDINE; CLONIDINE; DIGOXIN; DISOPYRAMIDE; LIDOCAINE; LITHIUM; METFORMIN; METHYLDOPA; PHENOTHIAZINE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL;

AGE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR RISK; CHEMOPROPHYLAXIS; CORONARY ARTERY DISEASE; HEART DEATH; HEART MUSCLE ISCHEMIA; HUMAN; LONG TERM CARE; MORBIDITY; NETHERLANDS; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; REVIEW; RISK REDUCTION; SURGICAL MORTALITY; SURGICAL PATIENT;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; CORONARY ARTERIOSCLEROSIS; DEATH, SUDDEN, CARDIAC; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 0842284084     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Mangano DT, Goldman L. Preoperative assessment of patients with known or suspected coronary disease. N Engl J Med 1995;333:1750-6.
2. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990;72:153-84.
3. Damen J, Poldermans D. Perioperatieve β-blokkade en niet-cardiale chirurgie: slowing the heart may save lives. Neth J Crit Care 2002;6(6):20-9.
4. Kertai MD, Poldermans D, Boersma E, Bax JJ, Leendertse K, Klein J, et al. Perioperatieve cardiale mortaliteit in 109.904 patiënten van het Erasmus MC [abstract]. Ned Tijdschr Anesthesiol 2002;15 Suppl:21.
5. Mangano DT, Hollenberg M, Fegert G, Meyer ML, London MJ, Tubau JF, et al. Perioperative myocardial ischemia in patients undergoing noncardiac surgery - I: incidence and severity during the 4 day perioperative period. J Am Coll Cardiol 1991;17:843-50.
6. Mangano DT, Wong MG, London MJ, Tubau JF, Rapp JA. Perioperative myocardial ischemia in patients undergoing non-cardiac surgery - II: incidence and severity during the 1st week after surgery. J Am Coll Cardiol 1991;17:851-7.
7. Wallace A, Layug B, Tateo I, Li J, Hollenberg M, Browner W, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998;88:7-17.
8. Zaugg M, Tagliente T, Lucchinetti E, Jacobs E, Krol M, Bodian C, et al. Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 1999;91:1674-86.
9. Poldermans D, Boersma E, Bax JJ, Thomson IR, Paelinck B, Ven LL van de, et al. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 2001;22:1353-8.
10. Gibson BE, Black S, Maass L, Cucchiara RF. Esmolol for the control of hypertension after neurologic surgery. Clin Pharmacol Ther 1988;44:650-3.
11. Stone JG, Foex P, Sear JW, Johnson LL, Khambatta HJ, Triner L. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 1988;68:495-500.
12. Raby KE, Brull SJ, Timimi F, Akhtar S, Rosenbaum S, Naimi C, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 1999;88:477-82.
13. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996;335:1713-20.
14. Poldermans D, Boersma E, Bax JJ, Thomson IR, Ven LL van de, Blankensteijn JD, et al. The effect of myocardial infarction in highrisk patients undergoing vascular surgery. N Engl J Med 1999;341:1789-94.
15. Schmidt M, Lindenauer PK, Fitzgerald JL, Benjamin EM. Forecasting the impact of a clinical practice guideline for perioperative beta-blockers to reduce cardiovascular morbidity and mortality. Arch Intern Med 2002;162:63-9
16. Rapchuk IL, Tonelli M, Rabuka S. Use of perioperative beta-blockade in Canadian patients undergoing non-cardiac surgery. Anesthesiology 2002;96:A1077.
17. Harwood TN, Butterworth J, Prielipp RC, Royster RL, Hansen K, Plonk G, et al. The safety and effectiveness of esmolol in the perioperative period in patients undergoing abdominal aortic surgery. J Cardiothorac Vasc Anesth 1999;13:555-61.
18. Davies MJ, Dysart RH, Silbert BS, Scott DA, Cook RJ. Prevention of tachycardia with atenolol pretreatment for carotid endarterectomy under cervical plexus blockade. Anaesth Intensive Care 1992;20:161-4.
19. Coleman AJ, Jordan C. Cardiovascular responses to anaesthesia. Influence of beta-adrenoreceptor blockade with metoprolol. Anaesthesia 1980;35:972-8.
20. Cucchiara RF, Benefiel DJ, Matteo RS, DeWood M, Albin MS. Evaluation of esmolol in controlling increases in heart rate and blood pressure during endotracheal intubation in patients undergoing carotid endarterectomy. Anesthesiology 1986;65:528-31.
21. Magnusson J, Thulin T, Werner O, Jarhult J, Thomson D. Haemodynamic effects of pretreatment with metoprolol in hypertensive patients undergoing surgery. Br J Anaesth 1986;58:251-60.
22. Jakobsen CJ, Bille S, Ahlburg P, Rybro L, Hjortholm K, Andresen EB. Perioperative metoprolol reduces the frequency of atrial fibrillation after thoracotomy for lung resection. J Cardiothorac Vasc Anesth 1997;11:746-51.
23. Urban MK, Markowitz SM, Gordon MA, Urquhart BL, Kligfield P. Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg 2000;90:1257-61.
24. Bayliff CD, Massel DR, Inculet RI, Malthaner RA, Quinton SD, Powell FS, et al. Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery. Ann Thorac Surg 1999;67:182-6.
25. Fleisher LA, Eagle KA. Clinical practice. Lowering cardiac risk in noncardiac surgery. N Engl J Med 2001;345:1677-82.
26. Auerbach AD, Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery. JAMA 2002;187:1435-44.
27. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-9.
28. Boersma E, Poldermans D, Bax JJ, Steyerberg EW, Thomson IR, Banga JD, et al. Predictors of cardiac events after major vascular surgery. Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2001;285:1865-73.
29. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2002;105:1257-67.
30. Akhtar S, Barash PG. Significance of beta-blockers in the perioperative period. Curr Opin Anesthesiol 2002;15:27-35.
31. Fleisher LA, Berry CE. Cost effectiveness of perioperative beta-blockade: a decision analytic model. Anesth Analg 2002;94:S-61.
32. Kertai MD, Boersma E, Bax JJ, Sozzi F, Bountioukos M, Roelandt JRTC, et al. De invloed van betablokkers op cardiale complicaties na een geslaagde operatie aan de grote vaten [abstract]. Ned Tijdschr Anesthesiol 2002;15 Suppl:21.
33. Martinez EA, Kim W, Faraday N, Pronovost PJ. Postoperative use of beta-blockers reduces mortality at one year in high risk surgical patients. Anesthesiology 2000;94:A-238.
34. Cruickshank JM. Beta-blockers continue to surprise us. Eur Heart J 2000;21:354-64.
35. Mabuchi N, Tsutamoto T, Kinoshita M. Therapeutic use of dopamine and beta-blockers modulates plasma interleukin-6 levels in patients with congestive heart failure. J Cardiovasc Pharmacol 2000;36 Suppl 2:S87-91.
36. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489-97.
37. Tafreshi MJ, Weinacker AB. Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma. Pharmacotherapy 1999;19:974-8.
38. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.
39. Radack K, Deck C. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. Arch Intern Med 1991;151:1769-76.
40. Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002;288:351-7.
41. Pollard JB, Chow RC, Hansen JR. Effectiveness of preprinted order forms in promoting perioperative beta-blocker use. Am J Health Syst Pharm 2002;59:359-60.
42. Wijeysundera DN, Beattie WS. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth Analg 2003;97:634-41.
43. Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 2003;114:742-52.
44. Shammash JB, Trost JC, Gold JM, Berlin JA, Golden MA, Kimmel SE. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 2001;141:148-53.
45. Sutton T, Rock P. Pro: beta-blockers should be used in all patients undergoing vascular surgery. J Cardiothorac Vasc Anesth 1999;13:490-5.
46. Ferguson jr TB, Coombs LP, Peterson ED. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 2002;287:2221-7.
47. Gattis WA, O'Connor CM, Leimberger JD, Felker GM, Adams KF, Gheorghiade M. Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure. Am J Cardiol 2003;91:169-74.
48. Sear JW, Howell SJ, Sear YM, Yeates D, Goldacre M, Foex P. Intercurrent drug therapy and perioperative cardiovascular mortality in elective and urgent/emergency surgical patients. Br J Anaesth 2001;86:506-12.
49. Boyd O, Street M. Is perioperative intensive care therapy useful in patients with limited cardiovascular reserve? Curr Opin Crit Care 1999;5:393-9.
50. Kern JW, Shoemaker WC. Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med 2002;30:1686-92.
51. Boyd O. Optimization of oxygenation and tissue perfusion in surgical patients. Curr Anaesth Crit Care 2002;13:206-14.
52. Sear JW, Foex P, Howell SJ. Effect of chronic intercurrent medication with beta-adrenoceptor blockade or calcium channel entry blockade on postoperative silent myocardial ischaemia. Br J Anaesth 2000;84:311-5.
53. Howell SJ, Sear YM, Yeates D, Goldacre M, Sear JW, Foex P. β-blockers and perioperative cardiovascular risk. Br J Anaesth 1999;82:458P.
54. Sear JW, George S, Sear YM, Foex P. Can we predict the development of postoperative cardiovascular complications in non-cardiac surgical patients? Br J Anaesth 1999;82 suppl 1:4.
55. Higham HE, Sear JW, Sear YM, Neill F, Foex P. Does perioperative silent myocardial ischemia predict long-term adverse outcome in surgical patients? Br J Anaesth 2000;85:651P-2P.
56. Akhtar S, Silverman DG, Senior A, Maning C, Barash PG. Preoperative beta-blocker use in high risk patients: is there room for improvement? Anesthesiology 2002;96:A224.